UBS Group AG - AERPIO PHARMACEUTICALS INC ownership

AERPIO PHARMACEUTICALS INC's ticker is ARPO and the CUSIP is 00810B105. A total of 1 filers reported holding AERPIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of AERPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$0
-100.0%
201
-93.7%
0.00%
Q1 2021$4,000
-81.0%
3,166
-85.5%
0.00%
Q4 2020$21,00021,804
+10802.0%
0.00%
Q3 2020$02000.0%0.00%
Q2 2020$0
-100.0%
200
-98.8%
0.00%
Q1 2020$9,000
+350.0%
16,376
+305.3%
0.00%
Q4 2019$2,000
-83.3%
4,040
-76.8%
0.00%
Q3 2019$12,000
-7.7%
17,447
+23.2%
0.00%
Q2 2019$13,000
+160.0%
14,167
+146.4%
0.00%
Q1 2019$5,0000.0%5,750
+109.9%
0.00%
Q4 2018$5,000
+66.7%
2,740
+180.7%
0.00%
Q3 2018$3,0009760.00%
Other shareholders

There were no reported owners of AERPIO PHARMACEUTICALS INC in Q3 2021.

NameSharesValueWeighting ↓
View complete list of AERPIO PHARMACEUTICALS INC shareholders